Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 
 
Blog Home
Bob Carey
Chief Market Strategist
Bio
X •  LinkedIn
 

  Biotechnology Continues To Attract Big Bucks From Venture Capitalists
Posted Under: Conceptual Investing
Supporting Image for Blog Post

 
View from the Observation Deck  
  1. From 2011-2014, of the 16 major categories tracked, the only one that raised more money from the venture capital (VC) industry than Biotechnology was Software.
  2. Biotechnology VC funding clearly outpaced funding for Medical Devices & Equipment and Health Care Services (see chart).
  3. The number of Biotechnology deals was fairly consistent over the four calendar years. The totals were as follows: 468 (2011); 478 (2012); 490 (2013) and 470 (2014).
  4. Biotechnology funding, which totaled $5.97 billion in 2014, surpassed the $4.0 billion mark in each of the four calendar years. Software VC funding ranged from $7.5 billion (2011) to $19.8 billion (2014).
  5. The strong interest in Biotechnology from VCs may be a signal that the momentum this sector has built up in recent years has legs, in our opinion. 
This chart is for illustrative purposes only and not indicative of any actual investment.

To Download a PDF of this post, please click here.
Posted on Thursday, March 26, 2015 @ 1:49 PM • Post Link Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts
MARKET ANALYSIS
Market Commentary and Analysis
Market Commentary Video
Monthly Talking Points
Quarterly Newsletter
Market Observations
Subscribe To Receive Email
 


 PREVIOUS POSTS
S&P 500 Dividend-Paying Stocks Distributing Record Levels Of Cash To Investors
Don't Fear the Dollar
A Snapshot From The Longest & Best Bull Market Ever
Two Of The Sectors At The Epicenter Of The Financial Crisis Are Still Recovering
Interest Rates, Valuations, and Free Ice Cream
Snapshot of U.S. Equity Styles/Market Caps
Retail Investors Have Favored Bonds Over Stocks In This Bull Market
Happy 6th Anniversary
Passive Investment Vehicles Still Exhibiting Strong Asset Growth
Back to NASDAQ 5,000, with an Important Difference
Archive
Skip Navigation Links.
Search by Topic
Skip Navigation Links.

 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2024 All rights reserved.